Contact this trialFirst, we need to learn more about you.
Chemotherapy
INCB000928 + Ruxolitinib for Myelofibrosis
Recruiting1 awardPhase 1 & 2
Saint Louis, Missouri
This trial is testing a new drug for people with myelofibrosis who are either transfusion-dependent or have symptomatic anemia. The trial will have two parts: dose escalation (finding the best dose) and expansion (a larger group of people testing the best dose).
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.